Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMasernfälle in den USA bis zum 31. August?
Masernfälle in den USA bis zum 31. August?
$21,423 Vol.
31. Aug. 2026
2750+
Ja
2400+
Ja
2450+
Ja
2500+
Ja
2550+
Ja
2600+
Ja
2650+
Yes
2700+
Yes
$21,423 Vol.
2750+
$3,369 Vol.
Ja
2400+
$2,169 Vol.
Ja
2450+
$774 Vol.
Ja
2500+
$1,695 Vol.
Ja
2550+
$4,813 Vol.
Ja
2600+
$4,424 Vol.
Ja
2650+
$2,609 Vol.
Yes
2700+
$1,571 Vol.
Yes
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Jul 31, 2026, 10:25 AM ET
Volumen
$21,423Enddatum
31. Aug. 2026Markt eröffnet
Jul 31, 2026, 10:25 AM ETAbwickler
0x65070BE91...Vorgeschlagenes Ergebnis: Ja
Kein Einspruch
Endgültiges Ergebnis: Ja
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$21,423Enddatum
31. Aug. 2026Markt eröffnet
Jul 31, 2026, 10:25 AM ETAbwickler
0x65070BE91...Vorgeschlagenes Ergebnis: Ja
Kein Einspruch
Endgültiges Ergebnis: Ja
Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen